Home
Refresh   Tag(s): ; ; ; ;
Add to My Group
February 13, 2008 at 05:35:55

View Ratings | Rate It

GSK Seroxat trial data - The outcome?

submit to twitter
submit to reddit
submit to digg
Tell A Friend

By Robert Fiddaman Dip.Couns MOC & MSFTR (about the author)     Page 1 of 2 page(s)

opednews.com     Permalink

For OpEdNews: Robert Fiddaman Dip.Couns MOC & MSFTR - Writer

I think we can all now accept that GlaxoSmithKline DID hold back negative results for 15 years regarding Seroxat safety in children. One only has to read the recently released court documents to see that GSK are guilty as sin.

As promised, I sent the documents to the MHRA in the hope of speeding up their sham of an investigation into GlaxoSmithKline. The MHRA replied to me with:

----- Original Message -----
From: MHRA Information Centre
To: fiddaman64



Sent: Thursday, February 07, 2008 3:04 PM

Subject: RE: GSK Investigation

Dear Bob Fiddaman,

Thank you for your recent enquiry to the MHRA. Thank you for sending us these documents, which we have passed on to those who are dealing with these matters

Please contact us again if you need further assistance with this, or any other queries.

Kind Regards,

Central Enquiry Point Information Centre Medicines and Healthcare products Regulatory Agency


Tel: 020 7084 2000

Personally I am in no doubt that GlaxoSmithKline and the MHRA are intertwined - one only has to look at my post from 10.33am today to see that staff at GSK looked in at my blog then a minute later staff from the MHRA looked in. Coincidence? I think not.

So what of the outcome?

It would be highly unlikely that the MHRA find GSK not guilty, particularly faced with the new evidence they have, though then again I have very little faith in the medicines regulator so it wouldn't surprise me if they actually did find GSK not guilty.

Let's say that they do find GSK guilty - what then?

Criminal proceeedings? Well if MHRA Chairman Alisdair Breckenridge is to be beleived then yes that is a possibilty, at least that is what he said when interviewed by Shelley Jofre on BBC TV's Panorama (See video 2.42) Breckenridge also said in the same Panorama programme:
"Remember Seroxat has never been licensed in children, it has never been licensed in children at all... but nevertheless practitioners have, on their own behest, have used it extensively. Our best evidence is that some 7,000 children a year were ... or children and adolescents were recieving Seroxat"(See video 1.00)

7,000 children a year? It just rolled off the tongue - meant nothing to Breckenridge. If the MHRA had done their job properly that 7,000 figure could have turned into a zero. But no, the MHRA stubbornly refused to accept that they had been duped by GlaxoSmithKline. Why would GSK dupe them?, they do after all have two ex-employees sitting on the board at the MHRA, of which Breckenridge is one, the other being Ian Hudson.

The MHRA have to ask themselves why 7,000 children a year were recieving Seroxat, they must hold up their hands and take some of the blame. If they decide to push for criminal proceedings against GlaxoSmithKline then they themselves must be impartially investigated and have criminal proceedings issued against them. They have failed to protect the very essence of life - Our children.

And what of GlaxoSmithKline mouthpiece Alistair Benbow?

When asked in 2003 if he thought the drug (Seroxat) could be still safe for children - he replied:

Next Page  1  |  2

 

http://fiddaman.blogspot.com/

The Medicines and Healthcare products Regulatory Agency (MHRA) - The FDA's equivalent in the UK - need a thorough impartial investigation. Their own Chief Executive refuses to budge on his stance that Seroxat (Paxil) is safe.

See (more...)
 

The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.

Contact Author Contact Editor View Authors' Articles

 

Book Recommendations for "GlaxoSmithKline Healthcare"
PDR Psychotropic Prescribing Guide 2006 9th Edition (GSK GlaxoSmithKline)
by PDR

$9.98

Number of pages: 603
Publisher: Thomson Healthcare Inc.

PDR 2008 5th Edition - Antiplatelet
by GlaxoSmithKline

$25.00

Number of pages:
Publisher: Thomson Healthcare

Antiplatelet
by GlaxoSmithKline

$34.99

Number of pages:
Publisher: Thomson Healthcare

View All Book Recommendations

Share this page: (what's this?)                   Tell a Friend: Tell A Friend

FACEBOOK      DIGG THIS      Add This Page to Mr Wong!           NEWSVINE      DEl.ICIO.US      Looksmart Furl      NETSCAPE      My Web      Tag!RawSugar      Blink List     (More...)

Comments: Expand   Shrink   Hide  
No comments

 
Want to post your own comment on this Article? Post Comment


 

 

 

Tell a Friend: Tell A Friend

Copyright © 2002-2009, OpEdNews

Powered by Populum